Registration for a live webinar on 'Gamma-delta T cells for immunotherapy of cancer' is now open.See webinar details
Prof. Jeffrey Weitzel City of Hope, USA1 Talk
Jeffrey N. Weitzel, MD is Founder of the Division of Clinical Cancer Genomics and the Cancer Screening & Prevention Program at City of Hope Comprehensive Cancer Center in Duarte, California. Board Certified in Clinical Genetics and Medical Oncology, Dr. Weitzel is a Professor of Oncology and Population Sciences at City... read moreof Hope, and holder of the Dr. Norman and Melinda Payson Professorship in Medical Oncology. He is also the ASCO Conquer Cancer Research Professor in Breast Cancer Disparities. At the vanguard of precision prevention, Dr. Weitzel’s multidisciplinary clinical, research, and training programs emphasize translational research in cancer disparities, genomic cancer risk assessment, chemoprevention, targeted therapy, clinical and psychosocial outcomes, genetic epidemiology and health services research, with a focus on underserved populations. He is member of the NCCN Genetics/Familial Risk Assessment practice guidelines committee. Dr. Weitzel is the principal investigator for the Clinical Cancer Genomics Community Research Network and received the American Society of Human Genetics Arno Motulsky-Barton Childs Award for Excellence in Human Genetics Education.